CRISPR Archives - Page 10 of 11

Stanford Human Germline Modification Meeting: Medicine, Science, Ethics, & Law

May 18, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

Last Thursday I participated in a meeting at Stanford Law School on human germline genetic modification hosted by Hank Greely (pictured at left), Professor of Law and Genetics at Stanford. The meeting was entitled, “Human Germline Modification: Medicine, Science, Ethics, and Law”. The panel included in addition to Hank and me, the following speakers: Marcy Darnovsky, Executive Director of …

Stanford Human Germline Modification Meeting: Medicine, Science, Ethics, & Law Read More »

Doudna most deserving of CRISPR Cas9 patent, says poll

May 3, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 4 Comments

With more than 250 votes cast, Jennifer Doudna is leading by a decisive margin in a poll asking who deserves the patent for use of CRISPR-Cas9 as a tool. Feng Zhang got only just over half the votes of Doudna. Another take home message from this poll is that a sizable minority–almost one in five– said …

Doudna most deserving of CRISPR Cas9 patent, says poll Read More »

News bites & rumors on human embryo genetic modification

April 30, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 8 Comments

A lot has happened in the week since the first human embryo genetic modification paper was published by a team led by Junjiu Huang. There have been a number of new events just in the last few days. Jocelyn Kaiser over at SCIENCEINSIDER has a new piece reporting a couple important developments including that the journal …

News bites & rumors on human embryo genetic modification Read More »

Who deserves patent for CRISPR-Cas9 in human cells? Take our poll

April 21, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 6 Comments

There is no hotter technology than CRISPR-Cas9 gene editing tools. Perhaps it is not surprising then that there is a patent dispute over it, which falls into two camps: (1) Jennifer Doudna & Emmanuelle Charpentier, and (2) Feng Zhang. Who deserves the intellectual property for use of CRISPR-Cas9 in human cells? Take our poll.

Jennifer Doudna Interview on CRISPR, Human Gene Editing

April 14, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

I’m doing a series of interviews with leaders in the field on human germline modification with the first interview in this series with George Church and today’s second in this series is a conversation I had with Dr. Jennifer Doudna, a pioneer in CRISPR-Cas9 technology. Doudna is a Professor in MCB and Chemistry as well …

Jennifer Doudna Interview on CRISPR, Human Gene Editing Read More »

Rumors flying on human embryo editing papers

April 9, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 1 Comment

We’ve all heard the human embryo editing rumors. There is a sense that human embryos have already been CRISPR’d. Rumors are rumors and they may mean not a whole lot, but there definitely is a huge buzz on this right now both in a positive sense and with concern. The excitement is over the power of …

Rumors flying on human embryo editing papers Read More »

5 new cool papers on CRISPR Cas9 gene editing

April 8, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

CRISPR Cas9 is a relatively new, powerful approach to gene editing and genetic modification more generally. In the relatively short window of time in which this technology has been widely available for gene editing applications it has already evolved rapidly to become more powerful. Here are some new papers of interest on this technology. With …

5 new cool papers on CRISPR Cas9 gene editing Read More »

TGIF: Stem Cell Stream of Consciousness Including CRISPR

April 3, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

It seems like Fridays are always a good time for reflection. It’s not like the scientist’s week ends on Friday sad to say, but still at least we can pause momentarily TGIF style and reflect on the maelstrom that is our lives, while cracking open another diet Coke or pouring another cup of coffee. This …

TGIF: Stem Cell Stream of Consciousness Including CRISPR Read More »

Practical Plan for Managing Human Germline CRISPR

March 20, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 4 Comments

CRISPR Cas9 gene editing technology is a game changer on many levels both inside and soon outside the lab. There is a growing sense of urgency amongst biomedical scientists to take a proactive approach to current and future use of CRISPR gene editing technology in human germ cells and embryos. These concerns have been heightened …

Practical Plan for Managing Human Germline CRISPR Read More »

ISSCR calls for moratorium on clinical application of human germline nuclear genome editing

March 19, 2015 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

The International Society for Stem Cell Research (ISSCR) just now released a new policy statement on human germline gene editing. The statement calls for a ban on clinical application of human germline gene editing technology. Here is the brief summary statement at the beginning: The International Society for Stem Cell Research calls for a moratorium on …

ISSCR calls for moratorium on clinical application of human germline nuclear genome editing Read More »